Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Chase · SciRah

Researcher profile · Semantic Scholar

D. Chase

Share profile

D. Chase — researcher profile on SciRah

h-index: 30
Works: 128
Citations: 3,597

Most-cited papers

Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
M. Mirza, D. Chase, B. Slomovitz, René dePont Christensen +27 more
2023New England Journal of Medicine686 citations Open access
Semantic Scholar
Uterine Microbiota: Residents, Tourists, or Invaders?
James M Baker, D. Chase, Melissa M. Herbst-Kralovetz
2018Frontiers in Immunology348 citations Open access
Semantic Scholar
Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling
Z. Ilhan, P. Łaniewski, N. Thomas, D. Roe +2 more
2019EBioMedicine248 citations Open access
Semantic Scholar
Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women
P. Łaniewski, D. Barnes, A. Goulder, Hai-Yan Cui +3 more
2018Scientific Reports237 citations Open access
Semantic Scholar
Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial
B. Monk, M. Barretina-Ginesta, B. Pothuri, I. Vergote +26 more
2024Annals of Oncology179 citations Open access
Semantic Scholar
The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment.
D. Chase, A. Goulder, F. Zenhausern, B. Monk +1 more
2015Gynecologic Oncology135 citations
Semantic Scholar
Hereditary predisposition to ovarian cancer, looking beyond BRCA1/BRCA2.
L. Minion, Jill S. Dolinsky, D. Chase, Charles L. M. Dunlop +2 more
2014Gynecologic Oncology111 citations Open access
Semantic Scholar
Factors Associated with Poor Quality of Life among Cervical Cancer Survivors: Implications for Clinical Care and Clinical Trials
K. Osann, Susie Hsieh, E. Nelson, B. Monk +3 more
2014Gynecologic Oncology104 citations Open access
Semantic Scholar
Features of the cervicovaginal microenvironment drive cancer biomarker signatures in patients across cervical carcinogenesis
P. Łaniewski, Hai-Yan Cui, D. Roe, D. Barnes +5 more
2019Scientific Reports88 citations Open access
Semantic Scholar
The development and use of vascular targeted therapy in ovarian cancer.
D. Chase, D. Chaplin, B. Monk
2017Gynecologic Oncology77 citations Open access
Semantic Scholar
Multi-omics data integration reveals metabolome as the top predictor of the cervicovaginal microenvironment
N. Bokulich, P. Łaniewski, Anja Adamov, D. Chase +2 more
2022PLoS Comput. Biol.72 citations Open access
Semantic Scholar
Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia
M. Kalantari, K. Osann, Itzel E. Calleja-Macias, S. Kim +5 more
2013Virology59 citations Open access
Semantic Scholar
Antiangiogenic agents as a maintenance strategy for advanced epithelial ovarian cancer.
B. Monk, H. Dalton, J. Farley, D. Chase +1 more
2013Critical reviews in oncology/hematology49 citations
Semantic Scholar
The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years
S. Gibson, G. Fleming, S. Temkin, D. Chase
2016Frontiers in Oncology45 citations Open access
Semantic Scholar
Retrospective review of symptoms and palliative care interventions in women with advanced cervical cancer
Y. Kim, M. Munsell, Ji Chan Park, L. Meyer +7 more
2015Gynecologic Oncology45 citations Open access
Semantic Scholar
Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment
C. Craig, B. Monk, J. Farley, D. Chase
2013Supportive Care in Cancer45 citations
Semantic Scholar
Cervicovaginal DNA Virome Alterations Are Associated with Genital Inflammation and Microbiota Composition
E. A. Kaelin, P. Skidmore, P. Łaniewski, L. Holland +3 more
2022mSystems44 citations Open access
Semantic Scholar
Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study.
D. Chase, Helen Q. Huang, L. Wenzel, D. Cella +4 more
2012Gynecologic Oncology43 citations
Semantic Scholar
Vaginal microbiota, genital inflammation, and neoplasia impact immune checkpoint protein profiles in the cervicovaginal microenvironment
P. Łaniewski, Hai-Yan Cui, D. Roe, D. Chase +1 more
2020npj Precision Oncology42 citations Open access
Semantic Scholar
Surgical management of recurrent ovarian cancer: the advantage of collaborative surgical management and a multidisciplinary approach.
E. Burton, D. Chase, Maki Yamamoto, Jayson de Guzman +2 more
2011Gynecologic Oncology41 citations
Semantic Scholar
Sexual Function of Endometrial Cancer Patients Enrolled on the Gynecologic Oncology Group LAP2 Study
J. Carter, Helen Q. Huang, D. Chase, J. Walker +2 more
2012International Journal of Gynecologic Cancer37 citations Open access
Semantic Scholar
Disparities in the Allocation of Treatment in Advanced Ovarian Cancer: Are There Certain Patient Characteristics Associated With Nonstandard Therapy?
D. Chase, S. Fedewa, T.-S. Chou, Amy Y. Chen +2 more
2012Obstetrics and Gynecology36 citations
Semantic Scholar
Implicit bias toward cervical cancer: Provider and training differences.
Juliana Liang, Katherine J Wolsiefer, Colin A. Zestcott, D. Chase +1 more
2019Gynecologic Oncology33 citations Open access
Semantic Scholar
The Challenge of Follow-Up in a Low-Income Colposcopy Clinic: Characteristics Associated With Noncompliance in High-Risk Populations
D. Chase, K. Osann, Nicole Sepina, L. Wenzel +1 more
2012Journal of Lower Genital Tract Disease26 citations Open access
Semantic Scholar
Disparities in Vulvar Cancer Reported by the National Cancer Database: Influence of Sociodemographic Factors
D. Chase, Chun C. Lin, C. Craig, S. Fedewa +4 more
2015Obstetrics and Gynecology21 citations
Semantic Scholar
Protein biomarkers in cervicovaginal lavages for detection of endometrial cancer
P. Łaniewski, Hai-Yan Cui, Nichole D. Mahnert, J. Mourad +5 more
2022Biomarker Research18 citations Open access
Semantic Scholar
Uterine Inflammatory Myofibroblastic Tumor Showing an Atypical ALK Signal Pattern by FISH and DES-ALK Fusion by RNA Sequencing: A Case Report.
S. Zarei, F. Abdul-Karim, D. Chase, C. Astbury +1 more
2020International Journal of Gynecological Pathology15 citations
Semantic Scholar
Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance
D. Chase, J. Perhanidis, D. Gupta, L. Kalilani +2 more
2023Oncology and Therapy14 citations Open access
Semantic Scholar
Gastrointestinal symptoms and diagnosis preceding ovarian cancer diagnosis: Effects on treatment allocation and potential diagnostic delay.
D. Chase, J. Neighbors, J. Perhanidis, B. Monk
2021Gynecologic Oncology14 citations
Semantic Scholar
Real world experience of poly (ADP-ribose) polymerase inhibitor use in a community oncology practice.
C. Eakin, A. Ewongwo, L. Pendleton, B. Monk +1 more
2020Gynecologic Oncology14 citations
Semantic Scholar
Appropriate Use of Complementary and Alternative Medicine Approaches in Gynecologic Cancers
D. Chase, S. Gibson, D. Sumner, J. Bea +1 more
2014Current Treatment Options in Oncology14 citations
Semantic Scholar
Correlation between progression-free survival and overall survival in patients with ovarian cancer after cytoreductive surgery: a systematic literature review
D. Chase, A. Mahajan, D. Scott, N. Hawkins +1 more
2023International Journal of Gynecological Cancer12 citations Open access
Semantic Scholar
Management of nausea and vomiting from poly(ADP-ribose) polymerase inhibitor therapy for advanced ovarian cancer.
C. Eakin, T. Norton, B. Monk, D. Chase
2020Gynecologic Oncology12 citations
Semantic Scholar
Safety and efficacy of salvage nano-particle albumin bound paclitaxel in recurrent cervical cancer: a feasibility study
L. Minion, D. Chase, J. Farley, L. Willmott +1 more
2015Gynecologic Oncology Research and Practice11 citations Open access
Semantic Scholar
Neurotoxicity in Ovarian Cancer Patients on Gynecologic Oncology Group (GOG) Protocol 218: Characteristics Associated with Toxicity and the Effect of Substitution with Docetaxel: An NRG Oncology/Gynecologic Oncology Group study
D. Chase, Helen Q. Huang, Cassandra D Foss, L. Wenzel +2 more
2014Gynecologic Oncology11 citations Open access
Semantic Scholar
Association of Multiple High-Risk Factors on Observed Outcomes in Real-World Patients With Advanced Ovarian Cancer Treated With First-Line Therapy
D. Chase, J. Perhanidis, D. Gupta, L. Kalilani +2 more
2023JCO Clinical Cancer Informatics9 citations Open access
Semantic Scholar
Patient-reported outcomes at discontinuation of anti-angiogenesis therapy in the randomized trial of chemotherapy with bevacizumab for advanced cervical cancer: An NRG Oncology Group study
D. Chase, Helen Q. Huang, B. Monk, L. Ramondetta +14 more
2020International Journal of Gynecological Cancer8 citations Open access
Semantic Scholar
Quality-adjusted time without symptoms of disease or toxicity and quality-adjusted progression-free survival with niraparib maintenance in first-line ovarian cancer in the PRIMA trial
M. Barretina-Ginesta, B. Monk, Sileny N. Han, B. Pothuri +16 more
2022Therapeutic Advances in Medical Oncology7 citations Open access
Semantic Scholar
Profile of olaparib in the treatment of advanced ovarian cancer
D. Chase, Shreya Patel, K. Shields
2016International Journal of Women's Health7 citations Open access
Semantic Scholar
Factors Associated With Grade 3-4 Treatment-Related Toxicity In Women With Advanced Or Recurrent Cervical Cancer: An Exploratory Analysis Of NRG Oncology/Gynecologic Oncology Group Trials (GOG) 179 And 204
D. Chase, J. Kauderer, L. Wenzel, L. Ramondetta +3 more
2015International Journal of Gynecologic Cancer7 citations Open access
Semantic Scholar
GOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase 3 trial of cemiplimab, an anti-PD-1, versus investigator's choice (IC) chemotherapy in ≥2 line recurrent or metastatic cervical cancer.
K. Tewari, I. Vergote, A. Oaknin, E. Alvarez +10 more
20185 citations
Semantic Scholar
Robotic-assisted gynecologic surgery in an older population: A comparison study.
M. Moore, E. Vo, B. Bhattarai, J. Farley +3 more
2023Journal of Geriatric Oncology4 citations Open access
Semantic Scholar
Dostarlimab for primary advanced or recurrent (A/R) endometrial cancer (EC): Outcomes by blinded independent central review (BICR) of the RUBY trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
M. Powell, S. Hietanen, R. Coleman, B. Monk +16 more
2023Journal of Clinical Oncology4 citations Open access
Semantic Scholar
17 Safety and patient-reported outcomes in patients receiving niraparib in the PRIMA/ENGOT-OV26/GOG-3012 trial
G. Freyer, B. Pothuri, S. Han, D. Chase +22 more
20204 citations Open access
Semantic Scholar
Updates on drug discovery in ovarian cancer
S. Gibson, K. Tewari, B. Monk, D. Chase
2014Gynecologic Oncology Research and Practice4 citations Open access
Semantic Scholar
Unwittingly biased: A note to gynecologic cancer providers.
D. Chase, R. Salani, J. Farley, Tara Torres +1 more
2021Gynecologic Oncology3 citations
Semantic Scholar
294 Patient-reported outcomes (PROS) in patients (PTS) receiving niraparib in the prima/engot-ov26/gog-3012 trial
J. Mäenpää, B. Pothuri, Sileny N. Han, D. Chase +6 more
20203 citations Open access
Semantic Scholar
A randomized, double-blind phase III trial of niraparib maintenance treatment in patients with HRD+ advanced ovarian cancer after response to front-line platinum-based chemotherapy.
A. González-Martín, F. Backes, K. Baumann, D. Chase +15 more
20163 citations
Semantic Scholar
Real-world experience of poly (ADP-ribose) polymerase inhibitor use in a community oncology practice: The clinical and financial burden
C. Eakin, A. Ewongwo, L. Pendleton, D. Chase +1 more
2020Gynecologic Oncology2 citations
Semantic Scholar
Integration of multi-omics data improves prediction of cervicovaginal microenvironment in cervical cancer
N. Bokulich, P. Łaniewski, D. Chase, J. Caporaso +1 more
2020medRxiv2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

B. Monk×26
Invite
B. Monk — researcher profile on SciRah
Melissa M. Herbst-Kralovetz×10
Invite
Melissa M. Herbst-Kralovetz — researcher profile on SciRah
P. Łaniewski×8
Invite
P. Łaniewski — researcher profile on SciRah
A. González-Martín×7
Invite
A. González-Martín — researcher profile on SciRah

×7

Invite

L. Wenzel — researcher profile on SciRah

Invite

B. Pothuri — researcher profile on SciRah

Invite

J. Farley — researcher profile on SciRah

Invite

D. Roe — researcher profile on SciRah

Invite

K. Tewari — researcher profile on SciRah

Invite

M. Mirza — researcher profile on SciRah

Invite

Hai-Yan Cui — researcher profile on SciRah

Invite

D. Cella — researcher profile on SciRah